Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - OPERATING EXPENSES
Operating Expenses LRMR - Larimar Therapeutics, Inc.
41.8 M
LAST VALUE
-9.03%
2 YEAR CAGR
-7.74%
5 YEAR CAGR
11.73%
10 YEAR CAGR